Tiziana Life Sciences Ltd
A biotechnology company working to develop innovative therapies for neurodegenerative and gastrointestinal diseases. It is developing intranasal immunotherapy for progressive multiple sclerosis, oral immunotherapy for Crohn's disease, and inhaled therapies for pulmonary diseases. Based in Bermuda.
Overview
Overview | |
|---|---|
Country | United Kingdom |
State | |
Employees | 9 |
Founded | 2013 |
Financials | |
|---|---|
Market Capitalization | 83.29M |
Revenue | |
Operating Income | -17.98M |
Operating Margin | |
Net Income | -17.69M |
Ranking
Operating Income
Operating Income Ranking | |
|---|---|
All | 3897 / 5373 |
Sector : Healthcare | 472 / 1144 |
Industry : Biotechnology | 167 / 645 |
Market Capitalization
Market Capitalization Ranking | |
|---|---|
All | 4204 / 5565 |
Sector : Healthcare | 732 / 1182 |
Industry : Biotechnology | 396 / 670 |
Net Income
Net Income Ranking | |
|---|---|
All | 3742 / 5436 |
Sector : Healthcare | 456 / 1164 |
Industry : Biotechnology | 174 / 659 |
Employees
Employees Ranking | |
|---|---|
All | 5024 / 5330 |
Sector : Healthcare | 1059 / 1174 |
Industry : Biotechnology | 572 / 667 |